These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3427175)

  • 41. A likelihood ratio test for cancer screening trials.
    Self SG; Etzioni R
    Biometrics; 1995 Mar; 51(1):44-50. PubMed ID: 7766795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addressing the current challenges of non-small-cell lung cancer clinical trial accrual.
    Curran WJ; Schiller JH; Wolkin AC; Comis RL;
    Clin Lung Cancer; 2008 Jul; 9(4):222-6. PubMed ID: 18650170
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Semiparametric estimation of proportional mean residual life model in presence of censoring.
    Chen YQ; Jewell NP; Lei X; Cheng SC
    Biometrics; 2005 Mar; 61(1):170-8. PubMed ID: 15737090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Consultants' forum: should post hoc sample size calculations be done?
    Walters SJ
    Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant radiotherapy for breast cancer: effects of longer follow-up.
    Van de Steene J; Vinh-Hung V; Cutuli B; Storme G
    Radiother Oncol; 2004 Jul; 72(1):35-43. PubMed ID: 15236872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of human trial design.
    Buiatti E
    IARC Sci Publ; 1996; (139):261-9. PubMed ID: 8923036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated significance tests for clinical trials with a fixed number of patients and variable follow-up.
    Armitage P; Stratton IM; Worthington HV
    Biometrics; 1985 Jun; 41(2):353-9. PubMed ID: 4027318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two-stage clinical trial stopping rules.
    Elashoff JD; Reedy TJ
    Biometrics; 1984 Sep; 40(3):791-5. PubMed ID: 6518247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stochastic modeling and prediction for accrual in clinical trials.
    Zhang X; Long Q
    Stat Med; 2010 Mar; 29(6):649-58. PubMed ID: 20082363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring treatment differences in long-term clinical trials.
    Canner PL
    Biometrics; 1977 Dec; 33(4):603-15. PubMed ID: 588655
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Joint monitoring and prediction of accrual and event times in clinical trials.
    Zhang X; Long Q
    Biom J; 2012 Nov; 54(6):735-49. PubMed ID: 22907686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monitoring clinical trials based on predictive probability of significance.
    Choi SC; Pepple PA
    Biometrics; 1989 Mar; 45(1):317-23. PubMed ID: 2720057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accrual by groups in trials with discrete-time survival endpoints.
    Jóźwiak K; Moerbeek M
    Clin Trials; 2013 Feb; 10(1):32-42. PubMed ID: 23203992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A two-stage procedure for bioequivalence studies.
    Racine-Poon A; Grieve AP; Flühler H; Smith AF
    Biometrics; 1987 Dec; 43(4):847-56. PubMed ID: 3427169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Planning the duration of accrual and follow-up for clinical trials.
    Morgan TM
    J Chronic Dis; 1985; 38(12):1009-18. PubMed ID: 4066889
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Planning survival studies to compare a treatment to an active control.
    Bristol DR
    J Biopharm Stat; 1993 Sep; 3(2):153-8. PubMed ID: 8220400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The design of a panel study under an alternating Poisson process assumption.
    Albert PS; Brown CH
    Biometrics; 1991 Sep; 47(3):921-32. PubMed ID: 1742446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determining the duration of comparative clinical trials while allowing for cure.
    Sposto R; Sather HN
    J Chronic Dis; 1985; 38(8):683-90. PubMed ID: 4019705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Calculating the number of patients necessary for designing a clinical study].
    Carné X; Moreno V; Porta Serra M; Velilla E
    Med Clin (Barc); 1989 Jan; 92(2):72-7. PubMed ID: 2709890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.